The FDA approved a labeling update that removes limitations on the use of the CAR T-cell therapy axicabtagene ciloleucel ...
NEW ORLEANS -- Loberamisal improved functional outcomes after acute ischemic stroke in a placebo-controlled phase III trial, ...
It's now been 32 years since publication of My Own Country, the powerful memoir of Abraham Verghese, MD, about his time as an ...
Oncology specialists should inform patients about a risk of serious toxicity related to dihydropyrimidine dehydrogenase (DPD) ...
The Trump administration on Thursday launched TrumpRx, a website it says will help patients buy prescription drugs directly ...
Last year, the FDA approved the first at-home test for cervical cancer screening. In a nationally representative survey, 20% of women said they would prefer at-home self-sampling for cervical cancer ...
NEW ORLEANS -- IV tenecteplase (TNKase) could be beneficial as far out as 24 hours after stroke onset in people not getting mechanical thrombectomy, the OPTION trial showed.
The Trump administration's move to give deportation officials access to Medicaid data is putting hospitals and states in a bind as they weigh whether to alert immigrant patients that their personal ...
President Trump signed a $1.2 trillion spending package this week, provisions of which could radically change the way ...
The FDA has requested that Amgen voluntarily withdraw avacopan (Tavneos), a treatment for anti-neutrophil cytoplasmic ...
"Indicating you can cure these significant mental conditions through diet is wildly dangerous." Psychiatrist Sasha Hamdani, ...
Documents obtained by the Guardian and the Associated Press undermine that testimony. Emails sent by staffers at the U.S. Embassy and the U.N. provide, for the first time, an inside look at how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results